PURPOSE: Autosomal dominant partial epilepsy with auditory features (ADPEAF) is a rare form of nonprogressive lateral temporal lobe epilepsy characterized by partial seizures with auditory disturbances. The gene predisposing to this syndrome was localized to a 10-cM region on chromosome 10q24. We assessed clinical features and linkage evidence in four newly ascertained families with ADPEAF, to refine the clinical phenotype and confirm the genetic localization. METHODS: We genotyped 41 individuals at seven microsatellite markers spanning the previously defined 10-cM minimal genetic region. We conducted two-point linkage analysis with the ANALYZE computer package, and multipoint parametric and nonparametric linkage analyses as implemented in GENEHUNTER2. RESULTS: In the four families, the number of individuals with idiopathic epilepsy ranged from three to nine. Epilepsy was focal in all of those with idiopathic epilepsy who could be classified. The proportion with auditory symptoms ranged from 67 to 100%. Other ictal symptoms also were reported; of these, sensory symptoms were most common. Linkage analysis showed a maximum 2-point LOD score of 1.86 at (theta=0.0 for marker D10S603, and a maximum multipoint LOD score of 2.93. CONCLUSIONS: These findings provide strong confirmation of linkage of a gene causing ADPEAF to chromosome 10q24. The results suggest that the susceptibility gene has a differential effect on the lateral temporal lobe, thereby producing the characteristic clinical features described here. Molecular studies aimed at the identification of the causative gene are underway.
PURPOSE: Autosomal dominant partial epilepsy with auditory features (ADPEAF) is a rare form of nonprogressive lateral temporal lobe epilepsy characterized by partial seizures with auditory disturbances. The gene predisposing to this syndrome was localized to a 10-cM region on chromosome 10q24. We assessed clinical features and linkage evidence in four newly ascertained families with ADPEAF, to refine the clinical phenotype and confirm the genetic localization. METHODS: We genotyped 41 individuals at seven microsatellite markers spanning the previously defined 10-cM minimal genetic region. We conducted two-point linkage analysis with the ANALYZE computer package, and multipoint parametric and nonparametric linkage analyses as implemented in GENEHUNTER2. RESULTS: In the four families, the number of individuals with idiopathic epilepsy ranged from three to nine. Epilepsy was focal in all of those with idiopathic epilepsy who could be classified. The proportion with auditory symptoms ranged from 67 to 100%. Other ictal symptoms also were reported; of these, sensory symptoms were most common. Linkage analysis showed a maximum 2-point LOD score of 1.86 at (theta=0.0 for marker D10S603, and a maximum multipoint LOD score of 2.93. CONCLUSIONS: These findings provide strong confirmation of linkage of a gene causing ADPEAF to chromosome 10q24. The results suggest that the susceptibility gene has a differential effect on the lateral temporal lobe, thereby producing the characteristic clinical features described here. Molecular studies aimed at the identification of the causative gene are underway.
Authors: A Escayg; B T MacDonald; M H Meisler; S Baulac; G Huberfeld; I An-Gourfinkel; A Brice; E LeGuern; B Moulard; D Chaigne; C Buresi; A Malafosse Journal: Nat Genet Date: 2000-04 Impact factor: 38.330
Authors: S Baulac; G Huberfeld; I Gourfinkel-An; G Mitropoulou; A Beranger; J F Prud'homme; M Baulac; A Brice; R Bruzzone; E LeGuern Journal: Nat Genet Date: 2001-05 Impact factor: 38.330
Authors: F Zara; E Gennaro; M Stabile; I Carbone; M Malacarne; L Majello; R Santangelo; F A de Falco; F D Bricarelli Journal: Am J Hum Genet Date: 2000-03-30 Impact factor: 11.025
Authors: M Durner; M A Keddache; L Tomasini; S Shinnar; S R Resor; J Cohen; C Harden; S L Moshe; D Rosenbaum; H Kang; K Ballaban-Gil; S Hertz; D R Labar; D Luciano; S Wallace; D Yohai; I Klotz; E Dicker; D A Greenberg Journal: Ann Neurol Date: 2001-03 Impact factor: 10.422
Authors: R Caraballo; S Pavek; A Lemainque; M Gastaldi; B Echenne; J Motte; P Genton; R Cersósimo; V Humbertclaude; N Fejerman; A P Monaco; M G Lathrop; J Rochette; P Szepetowski Journal: Am J Hum Genet Date: 2001-02-13 Impact factor: 11.025
Authors: M De Fusco; A Becchetti; A Patrignani; G Annesi; A Gambardella; A Quattrone; A Ballabio; E Wanke; G Casari Journal: Nat Genet Date: 2000-11 Impact factor: 38.330
Authors: E Flex; A Pizzuti; C Di Bonaventura; S Douzgou; G Egeo; J Fattouch; M Manfredi; B Dallapiccola; A T Giallonardo Journal: J Neurol Date: 2005-01 Impact factor: 4.849
Authors: Guillermo Horga; Eduard Parellada; Francisco Lomeña; Emilio Fernández-Egea; Anna Mané; Mireia Font; Carles Falcón; Anna B Konova; Javier Pavia; Domènec Ros; Miguel Bernardo Journal: J Psychiatry Neurosci Date: 2011-09 Impact factor: 6.186
Authors: Gary A Heiman; Kay Kamberakis; Richard Gill; Sergey Kalachikov; Timothy A Pedley; W Allen Hauser; Ruth Ottman Journal: Epilepsia Date: 2010-07-26 Impact factor: 5.864
Authors: R Ottman; M R Winawer; S Kalachikov; C Barker-Cummings; T C Gilliam; T A Pedley; W A Hauser Journal: Neurology Date: 2004-04-13 Impact factor: 9.910
Authors: Melodie Rose Winawer; Daniel Rabinowitz; Christie Barker-Cummings; Mark L Scheuer; Timothy A Pedley; W Allen Hauser; Ruth Ottman Journal: Epilepsia Date: 2003-09 Impact factor: 5.864